IPP Bureau
One more lab approved for batch-testing and release of Covid-19 vaccines
By IPP Bureau - August 17, 2021
National Institute of Animal Biotechnology, Hyderabad can now conduct quality checks and consequent lot release of Covid-19 vaccines
Centre allocates Rs 267.35 crores to Kerala for Covid response
By IPP Bureau - August 17, 2021
Rs one crore for each district to create medicine pool and support Centre of Excellence for Telemedicine
SCHOTT and Serum Institute announce JV for pharma packaging
By IPP Bureau - August 17, 2021
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
Indian pharma’s vaccine opportunity at US $ 10-11 billion
By IPP Bureau - August 17, 2021
Domestic market and developing countries will need doses of Indian vaccines
Zydus Cadila receives tentative approval for cancer drug
By IPP Bureau - August 17, 2021
Lenalidomide is used to treat cancer and also some anaemia disorders
Caplin Point Lab's subsidiary receives nod from Brazil's ANVISA for sterile injectable manufacturing site
By IPP Bureau - August 17, 2021
The approval allows it to market its products in the country
.jpg "Fortis Healthcare PAT at Rs 263.55 cr in Q1FY22")
Fortis Healthcare PAT at Rs 263.55 cr in Q1FY22
By IPP Bureau - August 16, 2021
It has initiated investments for advanced medical equipment such as Cath Labs, neuro microscopes, bone marrow transplant units at select facilities
Researchers develop remote ultrasound imaging using robotic technology
By IPP Bureau - August 16, 2021
The project is a collaboration between IIT Delhi and AIIMS
Aster DM Heathcare plans India expansion
By IPP Bureau - August 16, 2021
Investment of Rs 235 crores to add 411 beds in the next 18 months
IOL Chemicals and Pharma commissions Unit-10 for Rs 28.69 crores
By IPP Bureau - August 16, 2021
'Unit-9' for manufacturing Gabapentin & other pharma (APIs) products is expected to be complete in Q3FY22
Orchid Pharma reports net loss of Rs 30.90 cr in Q1FY22
By IPP Bureau - August 16, 2021
EPS for the period at Rs. (7.57)
Glenmark Pharmaceuticals net profit at Rs 306.52 crores in Q1FY22
By IPP Bureau - August 16, 2021
The company reports revenue growth of 26% and PAT growth of 21% YoY
Apollo Hospitals PAT at Rs 489.28 cr. in Q1FY22
By IPP Bureau - August 16, 2021
The hospital chain aggressively embarks on digitisation and is e-health ready
.jpg "Antiviral face mask capable of inactivating COVID19")
Antiviral face mask capable of inactivating COVID19
By IPP Bureau - August 16, 2021
The antiviral technology involves the presence of active positive charges on the fabric, as binding sites for viruses and on contact with the fabric, virus cells that are negatively charged are neutralised, leading to the rapid destruction of their glycoprotein layers and the release of non-infectious ribonucleic acid (RNA)
Zydus Cadila receives final approval for Mesalamine extended-release capsules
By IPP Bureau - August 16, 2021
The group has a total of 320 ANDA approvals
